Skip to content

Effort and yield of implementing EEG source localisation in presurgical epilepsy evaluation

Effort and yield of implementing EEG source localisation in presurgical epilepsy evaluation - Start-ESL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023852
Enrollment
75
Registered
2021-03-03
Start date
2021-07-12
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacoresistant focal epilepsy G40

Interventions

Group 1: 1) Assessment of the time spent for inhouse ESL during multimodal non-invasive presurgical epilepsy evaluation. 2) Comparison of ESL results to other diagnostic findings and, if applicable, t

Sponsors

Charité - Universitätsmedizin Berlin, Klinik für Neurologie, Epilepsie-Zentrum Berlin-Brandenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: Pharmacoresistant focal epilepsy; non-invasive evaluation for a first resective epilepsy surgery at the EZBB

Exclusion criteria

Exclusion criteria: Lack of written informed consent; skull defect

Design outcomes

Primary

MeasureTime frame
As a measure of the effort for ESL, the first primary endpoint is the working time for processing each single case as well as for installation and maintenance of the IT infrastructure per month. As a measure of the benefit of newly implemented ESL, the second primary endpoint is the concordance of selfmade ESL results (a) with externally processed, CE-certified ESL as external reference standard, and (b) with the resected brain area with respect to 12-month postsurgical seizure outcome.

Secondary

MeasureTime frame
Secondary endpoints include the concordance of ESL findings with results of other localising diagnostic methods (seizure semiology, MRI, etc.), a comparison of two non-commercial ESL software packages, the medical team's subjective estimation whether ESL brought a gain of knowledge for the individual case, and 12-month postsurgical outcome of the patients evaluated with ESL in comparison to matched control patients operated without ESL.

Countries

Germany

Contacts

Public ContactBernd Vorderwülbecke

Charité - Universitätsmedizin Berlin, Klinik für Neurologie

bernd.vorderwuelbecke@charite.de+49 (0)30 450 560 038

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026